CN Patent

CN1898240A — 咪唑并吡嗪类酪氨酸激酶抑制剂

Assigned to OSI Pharmaceuticals LLC · Expires 2007-01-17 · 19y expired

What this patent protects

本发明公开了式(I)的化合物及其可药用盐，其中Q 1 和R 1 如说明书中定义，其抑制IGF－1R酶并且可用于治疗和/或预防对通过抑制酪氨酸激酶的治疗有反应的多种疾病。

USPTO Abstract

本发明公开了式(I)的化合物及其可药用盐，其中Q 1 和R 1 如说明书中定义，其抑制IGF－1R酶并且可用于治疗和/或预防对通过抑制酪氨酸激酶的治疗有反应的多种疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN1898240A
Jurisdiction
CN
Classification
—
Expires
2007-01-17
Drug substance claim
No
Drug product claim
No
Assignee
OSI Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.